ARCA biopharma Inc (ABIO)

Finanzdaten der ARCA biopharma Inc-Aktie (ABIO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	17.91% 1.59	1.937	1.973	1.796	1.548
Depreciation and Amortization	25.00% 0.003	0.004	0.004	0.004	0.005
Operating Income/Loss	17.91% -1.59	-1.937	-1.973	-1.796	-1.548
Income/Loss From Continuing Operations Before Tax	23.53% -1.089	-1.424	-1.48	-1.346	-1.174
Income/Loss From Continuing Operations After Tax	23.53% -1.089	-1.424	-1.48	-1.346	-1.174
Net Income/Loss	23.53% -1.089	-1.424	-1.48	-1.346	-1.174
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.96% 0.00573	14.41	14.41	14.41	-
Diluted Average Shares	99.96% 0.00573	14.41	14.41	14.41	-
Basic Earnings Per Share	20.00% -0.08	-0.10	-0.10	-0.09	-0.08
Diluted Earnings Per Share	20.00% -0.08	-0.10	-0.10	-0.09	-0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-